| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 6 |
| 1 | ALBUTEROL SULFATE | 6 |
| 2 | CLINDAMYCIN | 5 |
| 3 | CLINDAMYCIN PHOSPHATE | 5 |
| 4 | LITHIUM | 5 |
| 5 | LITHIUM BROMATUM | 5 |
| 6 | ROSUVASTATIN | 5 |
| 7 | IBUPFROFEN | 4 |
| 8 | IBUPROFEN | 4 |
| 9 | IBUPROFEN 200 MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DONIDALORSEN | 1 | 0.0020 |
| 1 | CLINDAMYCIN PHOSPHATE | 5 | 0.0009 |
| 2 | FERRIC DERISOMALTOSE | 1 | 0.0007 |
| 3 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 4 | PYRIDOSTIGMINE BROMIDE ORAL | 2 | 0.0006 |
| 5 | PEGLOTICASE | 1 | 0.0003 |
| 6 | IDURSULFASE | 1 | 0.0003 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 8 | GLATIRAMER ACETATE INJECTION | 1 | 0.0002 |
| 9 | LITHIUM | 5 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 6 | Progesterone [EPC] | 1 | 0.0000 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 4 | 0.0000 |